• Inter-Rock Minerals Inc. published its MD&A for Q1 2026, posting revenue of US$24.4 million, gross profit of US$3.49 million, EBITDA of 919,000, net income of 429,000.
• Papillon revenue fell to US$24.3 million from US$28.1 million, while gross profit held at US$2.9 million on about 5% higher total volume; protein volumes were flat, protein margins improved, overall gross margin rose to 11.9% from 10.4%.
• MIN-AD revenue rose to US$2.6 million from US$2.2 million, supported by 8% higher volumes; gross profit increased to 588,000 from 538,000, with about 92% of volume sold to Papillon.
• Working capital totaled US$13.63 million, including about US$10.7 million cash; total debt was 797,000, with 300,000 drawn on MIN-AD revolving credit facility due at maturity in May 2026 and targeted for renewal.
• Management flagged increased competition as a driver of weaker quarter-on-quarter protein sales at Papillon; 2026 capital spending budget set at 400,000, with Q1 capex of 249,000 focused mainly on MIN-AD rail spur project.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inter-Rock Minerals Inc. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.